Grace Therapeutics's top three insider shareholders as of August 04, 2026 are Vimal Kavuru (Director, 1.19Mn shares), Donald Olds (Director, 381 shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Vimal Kavuru | - | 0 | 1,188,076 | 27 Sep, 2023 |
| Donald Olds | - | 381 | 0 | 05 Sep, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 08 Jan, 2026 | George Kottayil | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 08 Jan, 2026 | Vimal Kavuru | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 08 Jan, 2026 | Vimal Kavuru | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 08 Jan, 2026 | Vimal Kavuru | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 08 Jan, 2026 | Edward Neugeboren | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 08 Jan, 2026 | A Brian Davis | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 08 Jan, 2026 | Edward Neugeboren | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 08 Jan, 2026 | George Kottayil | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 08 Jan, 2026 | Edward Neugeboren | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 08 Jan, 2026 | George Kottayil | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 09 May, 2025 | George Kottayil | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 09 May, 2025 | George Kottayil | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 09 May, 2025 | Edward Neugeboren | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 09 May, 2025 | Vimal Kavuru | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 09 May, 2025 | Vimal Kavuru | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 09 May, 2025 | A Brian Davis | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 09 May, 2025 | Vimal Kavuru | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 09 May, 2025 | Edward Neugeboren | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 09 May, 2025 | George Kottayil | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |
| 09 May, 2025 | Edward Neugeboren | Stock Option (Right to Buy) | A | 10,000 | $0.00 | 10,000 | D | A |